Government Notifies New Drug Prices: NPPA Clarifies GST Applicability on 11 Formulations



Quick Summary
The National Pharmaceutical Pricing Authority (NPPA) has announced new retail prices for 11 drug formulations, including cardiovascular, antibiotic, and anti-diabetic medications. These prices, excluding Goods and Services Tax (GST), are now legally binding. Manufacturers can only add GST if it's actually payable to the government, preventing inflated costs for consumers. Companies must issue price lists and display them prominently, with non-compliance leading to recovery of overcharged amounts plus interest.

The National Pharmaceutical Pricing Authority (NPPA) has notified the retail prices of 11 new drug formulations, acting under the powers granted by the Drugs (Prices Control) Order, 2013. The detailed order, published in the Gazette of India, specifies the retail prices (excluding GST) along with the drug strengths, units, and the names of manufacturers and marketing companies. The notification, issued as S.O. 5476(E), applies to formulations submitted through Form-I for price fixation or revis
Daily Limit Reached

You have reached your daily limit of 2 Free News

Subscribe to CCI PRO for unlimited access

Why Upgrade to CCI PRO?
  • No Ads
  • WhatsApp Community
  • Daily E-Newsletter
  • Unlimited News Access
  • Profile Visitors
  • Link Social Profiles
  • Featured Job Posts
  • Pro Badge
  • Expert GST Guidance
  • Unlimited Forum Replies
  • Download Content in PDF
1 Year PLAN - Rs.1999
1799
(Excl. of GST ₹323)

2 Years PLAN - Rs.3499
3149
(Excl. of GST ₹566)

BEST VALUE
3 Years PLAN - Rs.4999
4499
(Excl. of GST ₹809)

View all CCI PRO benefits

Already a PRO member? Login here for an ad-free experience. 07941056694

FAQ :

The NPPA has notified the retail prices for 11 new drug formulations under the Drugs (Prices Control) Order, 2013.

The notification covers a range of drugs including cardiovascular, antibiotic, anti-allergic, anti-diabetic, and combination drugs.

Manufacturers may add GST only if it is actually payable to the government on the notified retail price, to avoid unjustified price inflation.

Manufacturers must issue a Form-V price list for all approved formulations from the date of notification and submit it to the NPPA, along with copies to State Drug Controllers and dealers.

If a manufacturer or marketer sells above the notified retail price, they will be required to deposit the overcharged amount with interest, and action will be taken under the DPCO 2013 and the Essential Commodities Act, 1955.

No, any previous price orders for these specific formulations, with the same strength and manufacturer/marketer, are superseded with immediate effect by this new notification.




News posted by

Finance news reporter covering taxation, GST, income tax, business compliance, and economy updates. I simplify complex financial topics into easy-to-understand articles for professionals, taxpayers, and business owners on leading finance and tax platforms.

Comments :


More »

Popular News





CCI Pro



Company
23 October 2026
Sr. Accountant

SANKARAN & KRISHNAN

New Delhi

B.Com

View Details
Company
15 October 2026
Senior Accountant

Continental Belting Pvt Ltd

Mumbai

B.Com

View Details
Company
ARTICLESHIP 22 October 2026
Articleship intern

Srinath Manikanta

Hyderabad

CA Inter

View Details
Company
ARTICLESHIP 07 November 2026
Article Assisstant

DPV & Associates

Chennai

CA Inter

View Details
Company
12 October 2026
Finance

I-Genext Consulting Private Limited

New Delhi

CA

View Details
Company
16 October 2026
CA article trainee

Zerdi & Co. Chartered Accountants

Pune

CA Inter

View Details
Company
ARTICLESHIP 25 October 2026
Article Intern (CA Articleship)

Arpan Bohra & Co

Hyderabad

CA Inter

View Details
Company
Featured ARTICLESHIP 28 October 2026
CA- Inter and Articles

N N V Satish & Co.,

Hyderabad

CA Inter

View Details